Results 31 to 40 of about 4,930 (199)

Clinical Prognostic Factors in Pediatric Patients With Orthostatic Intolerance

Global Pediatric Health, 2020
Midodrine is widely used for orthostatic intolerance (OI); however, little is known about the prognostic factors of OI after midodrine treatment. We retrospectively reviewed electronic medical charts to investigate clinical prognostic factors of OI on ...
Kazue Ishitsuka MD, MPH, PhD, Kaori Yamawaki MD, Miwako Horikawa MD, Hisaya Nakadate MD, PhD, Akira Nagai MD, PhD, Akira Ishiguro MD, PhD   +5 more
doaj   +1 more source

Use of Midodrine in Heart Failure: Two Case Reports and a Review of the Literature

European Journal of Case Reports in Internal Medicine, 2022
Hypotension in patients with heart failure is much more frequent in daily clinical practice than the 10–15% reported in clinical trials. In patients with heart failure with reduced ejection fraction (HFrEF), hypotension frequently limits the initiation ...
Adnan Hajjiah, Ossama Maadarani, Zouheir Bitar, Boutros Hanna, Ragab Elshabasy, Mohamed Abdelfatah, Mohammad Gohar   +6 more
doaj   +1 more source

The effect of fludrocortisone and midodrine on ambulatory blood pressure biomarkers and symptoms of syncope

Blood Pressure
Introduction Fludrocortisone and midodrine are frequently used to raise blood pressure (BP) in patients with vasovagal syncope (VVS)/low BP phenotype and orthostatic hypotension (OH), despite limited supporting evidence.
Kate Doyle, Ciara P. Rice, Rose Anne Kenny, Robert Briggs, Amanda H. Lavan   +4 more
doaj   +1 more source

Fludrocortisone Is Associated With a Higher Risk of All‐Cause Hospitalizations Compared With Midodrine in Patients With Orthostatic Hypotension

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundOrthostatic hypotension causes ≈80 000 hospitalizations per year in the United States. Treatments for orthostatic hypotension include fludrocortisone, a mineralocorticoid analog that promotes sodium reabsorption; and midodrine, an α‐1 ...
Carlos G. Grijalva, Italo Biaggioni, Marie R. Griffin, Cyndya A. Shibao   +3 more
doaj   +1 more source

Treatment via oral midodrine in a patient with prolonged hypotension following carotid artery stenting: a case report

Journal of Medical Case Reports, 2022
Background Hypotension and bradycardia are common hemodynamic complications following carotid artery stenting in patients with carotid artery stenosis.
Yaser Jenab, Kaveh Hosseini, Seyed-Mohammad Abtahi-Eivary   +2 more
doaj   +1 more source

Treatment of Vasovagal Syncope Associated with Asystole: Literature Review and Case Report of Long-term Follow-up

Рациональная фармакотерапия в кардиологии, 2021
Vasovagal syncope (VVS) can occur in every third of human population. Clinical symptoms of VVS areas a result of arterial hypotension with critical global cerebral hypoperfusion due to vasodilatation and bradicardia.
A. V. Pevzner, E. A. Kuchinskaya, V. G. Kiktev, G. I. Kheimets   +3 more
doaj   +1 more source

Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension

Annals of Clinical and Translational Neurology, 2020
Objective The efficacy and safety of 1‐month atomoxetine and midodrine therapies were compared. Three‐month atomoxetine and combination therapies were investigated for additional benefits.
Jung‐Ick Byun, Do‐Yong Kim, Jangsup Moon, Hye-Rim Shin, Jun‐Sang Sunwoo, Woo‐Jin Lee, Han‐Sang Lee, Kyung‐Il Park, Soon‐Tae Lee, Keun‐Hwa Jung, Ki‐Young Jung, Manho Kim, Sang Kun Lee, Kon Chu   +13 more
doaj   +1 more source

Prolonged Terlipressin Therapy as a Bridge to Curative TIPS for HRS-AKI in a Nontransplant Candidate. [PDF]

Case Reports Hepatol
Hepatorenal syndrome–acute kidney injury (HRS–AKI) is a severe complication of advanced cirrhosis with high mortality and limited treatment options. Terlipressin is currently the only FDA‐approved therapy for HRS, though recurrence is common upon discontinuation in patients without access to liver transplantation.
Reidy D, Jesudian A, Salerno D, Lucero C.   +3 more
europepmc   +2 more sources

Hypotensive Episodes Precede Cognitive Fluctuations in Parkinson's Disease Dementia

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Cognitive fluctuations (CFs) are a disabling feature in Parkinson's disease dementia (PDD) and contribute to caregiver burden. The relationship between CFs and neurogenic orthostatic hypotension (nOH), a common autonomic complication in PDD, has not been adequately examined.
Jorge Patino, Kevin Duque, Jesus Abanto, Aaron Bloemer, Heba Deraz, Alberto J. Espay, Abhimanyu Mahajan   +6 more
wiley   +1 more source

Continuous Apomorphine Infusion in Multiple System Atrophy Real‐World Insights From a French Nationwide Retrospective Cohort

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Continuous subcutaneous apomorphine infusion (CSAI) is effective in Parkinson's disease but has not been evaluated in multiple system atrophy (MSA). Objective To assess the 6‐month efficacy and tolerability of CSAI in MSA patients. Methods French multicenter retrospective registry‐based analysis of CSAI use in MSA.
Simon Lamy, Frederique Leh, Alexandra Foubert‐Samier, Soizic Leguy Bonnet, Guillaume Baille, Margherita Fabbri, Margaux Dunoyer, Lise Mantisi, Caroline Giordana, Anaïs El Ouartassi, Olivier Rascol, Wassilios G. Meissner, David Bendetowicz, Marie Vanel, David Grabli, Fabienne Ory‐Magne, Sophie Drapier   +16 more
wiley   +1 more source